Enhanced Validation

Polyclonal Anti-RBM39 Antibody

RNA binding motif protein 39
Recommended Applications
Genetic validation in WB by siRNA knockdown.
Product Description
Polyclonal Antibody against Human RBM39
Alternative Gene Names
CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2
Product Number
Unit Size
100 µl
Lot dependent
On Demand
On Demand
Target Protein
RNA binding motif protein 39
Target Gene
Antigen Sequence
Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence
Verified Species Reactivity
Interspecies Information

Highest antigen sequence identity to the following orthologs:

Rat ENSRNOG00000049814 (100%)

Mouse ENSMUSG00000027620 (100%)

40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Material Safety Data Sheet
Purification Method
Affinity purified using the PrEST antigen as affinity ligand
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.
Unit Size
100 µl
Current Lot
Produced on demand. Contact support@atlasantibodies.com for more information.
Product Data Sheet
Immunohistochemistry (IHC)

Recommended conditions:

Dilution: 1:50 - 1:200

Retrieval method: HIER pH6

Western Blot (WB)

Recommended conditions:

Working concentration: 0.04-0.4 µg/ml

Western Blot (WB)

Genetic validation in WB by siRNA knockdown.

Protein Name
RNA binding motif protein 39
Gene Name
Alternative Gene Names
CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2
UniProt ID
Gene (Ensembl)
Entrez Gene ID
Normally shipped at ambient temperature
Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Human Protein Atlas

This antibody has been used for staining of 44 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type. The results are part of an ongoing effort to map the human proteome using antibodies.

All characterization data for ENSG00000131051 on the Human Protein Atlas

Pogacar Z, Groot K, Jochems F, Dos Santos Dias M, Mulero-Sánchez A, Morris B, Roosen M, Wardak L, De Conti G, Velds A, Lieftink C, Thijssen B, Beijersbergen RL, Bernards R, Leite de Oliveira R

Genetic and compound screens uncover factors modulating cancer cell response to indisulam

Life Sci Alliance , 2022 May 9; 5(9):e202101348. Epub 2022 May 9

PubMed ID: 35534224 DOI: 10.26508/lsa.202101348

Nijhuis A, Sikka A, Yogev O, Herendi L, Balcells C, Ma Y, Poon E, Eckold C, Valbuena GN, Xu Y, Liu Y, da Costa BM, Gruet M, Wickremesinghe C, Benito A, Kramer H, Montoya A, Carling D, Want EJ, Jamin Y, Chesler L, Keun HC

Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma

Nat Commun , 2022 Mar 16; 13:1380. Epub 2022 Mar 16

PubMed ID: 35296644 DOI: 10.1038/s41467-022-28907-3

Yamanaka S, Horiuchi Y, Matsuoka S, Kido K, Nishino K, Maeno M, Shibata N, Kosako H, Sawasaki T

A proximity biotinylation-based approach to identify protein-E3 ligase interactions induced by PROTACs and molecular glues

Nat Commun , 2022 Jan 10; 13:183. Epub 2022 Jan 10

PubMed ID: 35013300 DOI: 10.1038/s41467-021-27818-z

Lu SX, De Neef E, Thomas JD, Sabio E, Rousseau B, Gigoux M, Knorr DA, Greenbaum B, Elhanati Y, Hogg SJ, Chow A, Ghosh A, Xie A, Zamarin D, Cui D, Erickson C, Singer M, Cho H, Wang E, Lu B, Durham BH, Shah H, Chowell D, Gabel AM, Shen Y, Liu J, Jin J, Rhodes MC, Taylor RE, Molina H, Wolchok JD, Merghoub T, Diaz LA Jr, Abdel-Wahab O, Bradley RK

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity

Cell , 2021 Jun 24; 184(15):4032-4047.e31. Epub 2021 Jun 24

PubMed ID: 34171309 DOI: 10.1016/j.cell.2021.05.038

Gaucherand L, Porter BK, Levene RE, Price EL, Schmaling SK, Rycroft CH, Kevorkian Y, McCormick C, Khaperskyy DA, Gaglia MM

The Influenza A Virus Endoribonuclease PA-X Usurps Host mRNA Processing Machinery to Limit Host Gene Expression

Cell Rep , 2019 Apr 16; 27(3):776-792.e7. Epub 2019 Apr 16

PubMed ID: 30995476 DOI: 10.1016/j.celrep.2019.03.063

Lu G, Weng S, Matyskiela M, Zheng X, Fang W, Wood S, Surka C, Mizukoshi R, Lu CC, Mendy D, Jang IS, Wang K, Marella M, Couto S, Cathers B, Carmichael J, Chamberlain P, Rolfe M

UBE2G1 governs the destruction of cereblon neomorphic substrates

eLife , 2018 Sep 20; 7:e40958. Epub 2018 Sep 20

PubMed ID: 30234487 DOI: 10.7554/eLife.40958

Faherty N, Benson M, Sharma E, Lee A, Howarth A, Lockstone H, Ebner D, Bhattacharya S

Negative autoregulation of BMP dependent transcription by SIN3B splicing reveals a role for RBM39

Sci Rep , 2016 Jun 21; 6:28210. Epub 2016 Jun 21

PubMed ID: 27324164 DOI: 10.1038/srep28210

Sillars-Hardebol AH, Carvalho B, Beliën JA, de Wit M, Delis-van Diemen PM, Tijssen M, van de Wiel MA, Pontén F, Meijer GA, Fijneman RJ

CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.

Cell Oncol (Dordr) , 2012 Aug; 35(4):293-300. Epub 2012 Jun 19

PubMed ID: 22711543 DOI: 10.1007/s13402-012-0088-2

Did we miss your publication?

Have you published using HPA001591? Please let us know and we will be happy to include your reference on this page.

Read more

Join the Explorer Program

Are you using our products in an application or species we have not yet tested? Why not participate in the Explorer Program, and we will show your contribution here. If you would like to share your results with us, the Explorer Program offers a 25µl vial free of charge with your next order.

Read more

Corresponding Antigens


Our customer support and expert scientific support teams are here to help you succeed in your research.

Get in touch